Search of biomarkers related to the therapeutic effect of sublingual immunotherapy with epigenome analysis
Not Applicable
Recruiting
- Conditions
- Japanese cedar pollinosis
- Registration Number
- JPRN-UMIN000023910
- Lead Sponsor
- ippon Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria included severe asthma cases or malignant tumors, such as collagen disease merger example, it is contraindicated patients with sublingual immunotherapy therapeutic agent Shidatoren.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Epigenome analysis of before and after treatment
- Secondary Outcome Measures
Name Time Method